Analysis of copper and zinc plasma concentration and the efficacy of zinc therapy in individuals with Asperger's Syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS) and autism

Biomarker Insights

Volumn 6, Issue , 2011, Pages 127-133

  Russo, A J ^a,b   de Vito, Robert ^a  

^a Health Research Institute   (United States)

^b HARTWICK COLLEGE   (United States)

Author keywords

Asperger's disorder; Autism; Copper; PDD NOS; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COPPER; MAGNESIUM; MANGANESE; PYRIDOXINE; ZINC;

ARTICLE; ASPERGER SYNDROME; ATTENTION; AUTISM; AWARENESS; CHILD; CLINICAL FEATURE; COPPER BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HEARING ACUITY; HUMAN; HYPERACTIVITY; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; SEIZURE; SYMPTOM; TOUCH; VISION; ZINC BLOOD LEVEL;

EID: 83455210287     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S7286     Document Type: Article

References (62)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR (fourth edition, text revision). Washington DC: American Psychiatric Association, 2000.
2. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. J Am Med Assoc. 2003;289: 49-55.
3. Schanen CN. Epigenetics of autism spectrum disorders. Human Molecular Genetics. 2006;15:138-50.
4. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 2003;33:365-82.
5. Barrett S, Beck JC, Bernier R, et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet. 1999;88: 609-15.
6. International Molecular Genetics Study of Autism Consortium. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet. 2001;10:973-82.
7. Yonan AL, Alarcon M, Cheng R, et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet. 2003;73:886-97.
8. Hutcheson HB, Olson LM, Bradford Y, et al. Examination of NRCAM, LRRN3, KIAA0716, and LAMB1 as autism candidate genes. BMC Med Genet. 2004;5:12.
9. Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006;27:S128-36.
10. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005;51:77-85.
11. White JF. Intestinal Pathophysiology in Autism Exp Biol Med (Maywood). 2003;228:639-49.
12. Russo AJ, Krigsman A, Jepson B, Wakefield A. Low serum Alpha-1 Antitrypsin Associated with Anti-PR3 ANCA in Autistic children with GI Disease. Genomics Insights. 2009;2:1-9.
13. Russo AJ, Krigsman A, Jepson B, Wakefield A. Anti-PR3 and anti-MPO IgG ANCA in autistic children with chronic GI disease. Immunology and Immunogenetics Insights. 2009;2:21-8.
14. Russo AJ. Anti-Metallothionein IgG and levels of metallothionein in autistic families. Swiss Med Weekly. 2008;138(5-6):70-7.
15. Russo AJ. Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease. Drug, Healthcare and Patient Safety. 2009;1: 1-8.
16. Raulin J. Etudes clinique sur la vegetation. Annales des Scienceas Naturelle: Botanique. 1869;11:93-299.
17. Maze P. Influences respectives des elements de la solution gmineral du mais. Annales de l'Institut Pasteur (Paris). 1914;28:21-69.
18. Todd WR, Elvehjem CA, Hart EB. Zinc in the nutrition of the rat. American Journal of Physiology. 1934;107:146-56.
19. Vallee BL, Auld DS. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry. 1990;29:5647-59.
20. Miller WJ, Blackmon DM, Gentry RP, Pitts WJ, Powell GW. Absorption, excretion, and retention of orally administered zinc-65 in various tissues of zinc-deficient and normal goats and calves. Journal of Nutrition. 1967;92: 71-8.
21. Brown RS, Sander C, Argos P. The primary structure of transcription factor IIIA has 12 consecutive repeats. FEBS Letters. 1985;186:271-4.
22. McNulty TJ, Taylor CW. Extracellular heavy-metal ions stimulate Ca2+ mobilization in hepatocytes. Biochemical Journal. 1999;339(Pt 3): 555-61.
23. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6 quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochemical Journal. 1993;296:403-8.
24. Prasad AS. Clinical manifestations of zinc deficiency. Annual Review of Nutrition. 1985;5:341-63.
25. Cunnane SC. Role of zinc in lipid and fatty acid metabolism and in membranes. Progress in Food and Nutrition Science. 1988;12:151-88.
26. Endre L, Katona Z, Gyurkovits K. Zinc deficiency and cellular immune deficiency in acrodermatitis enteropathica. Lancet. 1975;2:119-6.
27. Aggett PJ. Acrodermatitis enteropathica. Journal of Inherited Metabolic Disease. 1983;1:39-43.
28. Halsted JA, Ronaghy HA, Abadi P. Zinc deficiency in man. American Journal of Medicine. 1972;53:277-84.
29. Prasad AS. Role of zinc in human health. Boletin de la Asociacion Medica de Puerto Rico. 1991;83:558-60.
30. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiological Reviews. 1993;73:79-118.
31. Hambidge M. Human zinc deficiency. J Nutr. 2000;130(5S Suppl): 1344S-1349S.
32. Ho E, Ames B. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci U S A. 2002;99(26):16770-5.
33. Song Y, et al. Zinc Deficiency Affects DNA Damage, Oxidative Stress, Antioxidant Defenses, and DNA Repair in Rats. Journal of Nutrition. 2009; 139:1626-31.
34. Powell S. The Antioxidant Properties of Zinc. Journal of Nutrition. 2000; 130:1447S-1454S.
35. Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev. 2005;49:633-40.
36. Arnaud P, Gianazza E, Miribel L. Ceruloplasmin. Methods Enzymol. 1988; 163:441-52.
37. Horn N, Tonnesen T, Tumer Z. Menkes disease: an X-linked neurological disorder of the copper metabolism. Brain Pathol. 1992;2:351-62.
38. Wendland BE, Greenwood CE, Weinberg I, Young KW. Malnutrition in institutionalized seniors: the iatrogenic component. J Am Geriatr Soc. 2003; 51:85-90.
39. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006;81:1371-84.
40. Kassu A, Yabutani T, Mahmud ZH, et al. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur J Clin Nutr. 2006;60:580-6.
41. Ko WS, Guo CH, Yeh MS, et al. Blood micronutrient, oxidative stress and viral load in patients with chronic hepatitis. C World J Gastroenterol. 2005; 11:4697-702.
42. Molteni A, Ward WF, Kim YT, et al. Serum copper concentration as an index of clinical lung injury. Adv Exp Med Biol. 1989;258:273-85.
43. Das SK, Ray K. Wilson's disease: an update. Nat Clin Pract Neurol. 2006;2: 482-93.
44. Wapnir RA. Copper absorption and bioavailability. Am J Clin Nutr. 1998;67: 141-3.
45. Yilmaz A, Sari RA, Gundogdu M, Kose N, Dag E. Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus. Clin Rheumatol. 2005;24:331-5.
46. Chauhan A, et al. Increased Copper-Mediated Oxidation of Membrane Phosphatidylethanolamine in Autism. American Journal of Biochemistry and Biotechnology. 2008;4(2):95-100.
47. Collins A, et al. Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics. 2006;7(3):167-74.
48. Ma DQ, et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet. 2005; 77(3):377-88.
49. Ashley-Koch AE, et al. An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Ann Hum Genet. May 2006;70(Pt 3):281-92.
50. Xie X, Smart T. Properties of GABA-mediated synaptic potentials induced by zinc in adult rat hippocampal pyramidal neurones. J Physiol. 1993;460:503-23.
51. Ben-Ari Y, Cherubini E. Zinc and GABA in developing brain. Nature. 1991;353:220.
52. Takeda A, Hirate M, Tamano H, Oku N. Release of glutamate and GABA in the hippocampus under zinc deficiency. J Neurosci Res. 2003;72(4): 537-42.
53. Takeda A, Itoh H, Imano S, Oku N. Impairment of GABAergic neurotransmitter system in the amygdala of young rats after 4-week zinc deprivation. Neurochem Int. 2006;49(8):746-50.
54. Sharonova IN, Vorobjev VS, Haas HL. High-affinity copper block of GABA(A) receptor-mediated currents in acutely isolated cerebellar Purkinje cells of the rat. Eur J Neurosci. 1998;10(2):522-8.
55. Kim H, Macdonald RL. An N-Terminal Histidine Is the Primary Determinant of α Subunit-Dependent Cu2+ Sensitivity of αβ3γ2 L GABAA Receptors. Molecular Pharmacology. 2003;64:1145-52.
56. Lake CR, Ziegler MG, Murphy DL. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry. May 1977;34(5):553-6.
57. Rahman K, et al. Dopamine-β-Hydroxylase (DBH), Its Cofactors and Other Biochemical Parameters in the Serum of Neurological Patients in Bangladesh. Int J Biomed Sci. 2009;5(4):395-401.
58. Deinum J, et al. DBH gene variants that cause low plasma dopamine β hydroxylase with or without a severe orthostatic syndrome. J Med Genet. 2004;41:e38 doi:10.
59. Prasad AS. The role of zinc in gastrointestinal and liver disease. Clin Gastroenterol. Sep 1983;12(3):713-41.
60. Prasad AS. Clinical manifestations of zinc deficiency. Annu Rev Nutr. 1985; 5:341-63.
61. King JC, Cousins RJ. Zinc. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease. 10th ed. Baltimore: Lippincott Williams & Wilkins. 2006:271-85.
62. Tanner S, Baranov V, Bandura D. Reaction cells and collision cells for ICP-MS: a tutorial review. Spectrochimica Acta. 2002;57:1361-452.